Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03002428 · ClinicalTrials.gov registry record · Phase 3

A Comparison of PF708 and Forteo in Osteoporosis Patients

A Phase 3 study of Osteoporosis, sponsored by Pfenex.

Completed
Registry status
Phase 3
Development phase
181
Enrollment target
20
Study locations

NCT03002428 is a Phase 3 study of Osteoporosis that has completed, run by Pfenex. The registered enrollment target is 181 participants, below the 1,544-participant average among 84 other Osteoporosis trials with a reported enrollment target (88% lower). The trial reports 20 study locations across 13 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03002428, a Phase 3 study of Osteoporosis, has completed, sponsored by Pfenex.

COMPLETED
Registry status
Phase 3
Development phase
181 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to compare the effects of two teriparatide products, PF708 and Forteo, in patients with osteoporosis.

Conditions Studied

Osteoporosis

Interventions

  • DRUG Teriparatide (PF708)
  • DRUG Teriparatide (Forteo)

Study Locations (20)

Arizona

  • Radiant Research - Chandler
  • Radiant Research - Mesa
  • SunValley Arthritis Center - Peoria
  • Radiant Research - Phoenix

Alabama

  • Radiant Research - Birmingham
  • The Orthopaedic Group - Mobile

Nevada

  • Radiant Research - Henderson
  • Radiant Research - Las Vegas

Ohio

  • Radiant Research - Akron
  • Radiant Research - Cincinnati

Pennsylvania

  • Altoona Center for Clinical Research - Duncansville
  • Pennsylvania Regional Center for Arthritis & Osteoporosis Research - Wyomissing

Colorado

  • Radiant Research - Colorado Springs

Florida

  • OB-GYN Associates of Mid-Florida - Leesburg

Georgia

  • Atlanta Research Center - Atlanta

Trial Details

FieldValue
Enrollment Target 181 participants
Start Date 2016-12
Est. Completion 2018-05
Phase Phase 3

Sponsor

Pfenex

3 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03002428

The ClinicalTrials.gov registry entry for NCT03002428 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 181 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,544-participant average among 84 other Osteoporosis trials with a reported enrollment target (88% lower). The listed sponsor is Pfenex, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Osteoporosis appearing as the primary indexed condition, and to 2 interventions - of which Teriparatide (PF708) is the first listed.

NCT03002428 reports 20 study locations spanning 13 distinct geographic areas - top geographies include Arizona, Alabama, Nevada.

Frequently Asked Questions

What is clinical trial NCT03002428 about?

NCT03002428 is a clinical study titled "A Comparison of PF708 and Forteo in Osteoporosis Patients". The purpose of this study is to compare the effects of two teriparatide products, PF708 and Forteo, in patients with osteoporosis.

What is the current status of trial NCT03002428?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 181 participants. The study started on 2016-12. Estimated completion is 2018-05.

What conditions does trial NCT03002428 study?

This clinical trial studies the following conditions: Osteoporosis.

What interventions are being tested in trial NCT03002428?

The interventions under investigation include: Teriparatide (PF708) (DRUG), Teriparatide (Forteo) (DRUG).

Who is sponsoring clinical trial NCT03002428?

This trial is sponsored by Pfenex, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03002428 being conducted?

This trial has 20 study locations across Alabama, Arizona, Colorado, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Osteoporosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Osteoporosis

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.